decisionhealth Newsletters, Part B News - 2008 Issue 1 (January)
DEA faces pressure to upgrade e-prescribing rules
Subscribe or sign in to view the full article.
Article Overview
This article discusses pressure on the DEA and the Department of Justice to revisit long-standing restrictions affecting electronic prescribing of controlled substances, along with a related push by SureScripts to increase public awareness of e-prescribing in pharmacies. It is relevant to physicians, pharmacists, health IT stakeholders, compliance professionals, and anyone tracking federal policy and adoption trends in electronic prescribing. The article also touches on reported growth in e-prescribing volume and the general market outlook for network-based prescription transmission.
Why This Topic Matters
Policy changes around e-prescribing can affect workflow, compliance, and adoption of health information technology. The article also highlights how industry outreach and network growth may influence the shift away from paper prescriptions.
What You Will Learn
- Why federal e-prescribing rules for controlled substances are being revisited
- How industry groups are promoting awareness of e-prescribing in pharmacies
- What reported adoption trends suggest about electronic prescription volume
- How policy and market factors may influence e-prescribing growth
Who Should Read This
- Physicians
- Pharmacists
- Health IT professionals
- Compliance and regulatory staff
- Medical practice administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com